• Home
  • Columbus Day Program

Columbus Day Program

  • 12 Oct 2015
  • 8:00 AM - 3:00 PM
  • Radisson Downtown Manchester
  • 120


  • Must register by September 28th
  • Must register by September 28th
  • Must register by September 28th
  • Exhibitor Fee for Vendors

Registration is closed

Program Details:

STEPPing up Teamwork to Positively Impact Patient Safety

1) Outline the five key principles of TeamSTEPPS.

2) Discuss the impact of teamwork on interdisciplinary communication and patient safety.

3) Discuss case-based scenarios as they relate to TeamSTEPPS concepts.

4) Identify TeamSTEPPS tools & strategies pharmacists and pharmacy technicians can utilize in their daily practice.

Controlled Substance Drug Diversion: What Keeps Us Up at Night and Closing the Gaps to Get a Full Night’s Sleep

1) Describe a hospital’s experience around control substance drug diversion and a regulatory agency’s internal investigation.

2) Discuss the specific drug diversion process improvement initiatives, policy development, and optimization between pharmacy, nursing, anesthesia, and hospital security.

3) Outline the lessons learned and potential system gaps when implementing a comprehensive diversion surveillance program and consistent compliance around regulatory reporting requirements.

Withdrawal in Our Smallest Patients: Pharmacological Treatment of Neonatal Abstinence Syndrome

1) Examine the risks and benefits of pharmacological treatment for neonatal abstinence syndrome (NAS) to the patient.

2) Discuss pharmacological options for the management of NAS.

3) Compare evidence-based NAS management strategies.

Waiting to Inhale: An Update on COPD

1) Recommend appropriate treatment options for patients with COPD based upon patient factors.

2) Examine the evidence for new COPD pharmacotherapeutic agents.

3) Identify patient characteristics associated with treatment non-compliance.

New Era of Treating Hepatitis C: Current Treatment Options and Clinical Considerations for the Pharmacist

1) Identify new treatment options and the literature supporting their use in Hepatitis C.

2) Differentiate between treatment options based on genotype.

3) Discuss adverse effects of new medications.

4) Identify important drug-drug interactions.

5) Apply a Hepatitis C treatment algorithm to a patient case.

New Hampshire Society of Health System Pharmacists

Powered by Wild Apricot Membership Software